Schep LJ, Slaughter RJ, Beasley DM. The clinical toxicology of metamfetamine. Clin Toxicol (Phila) 2010;48 :675–694
Won S, Hong RA, Shohet RV, Seto TB, Parikh NI. Methamphetamine-Associated Cardiomyopathy. Clinical cardiology. 2013;36(12):737-742.
Paratz ED, Cunningham NJ, MacIsaac AI. The Cardiac Complications of Methamphetamines. Heart Lung Circ. 2016 Apr;25(4):325-32.
Andrejak M, Tribouilloy C. Drug-induced valvular heart disease: an update. Arch Cardiovasc Dis. 2013 May;106(5):333-9.
Yaghoubi A, Safaie N, Azarfarin R, Alizadehasl A, Golzari SEJ. Evaluation of cardiovascular diseases and their risk factors in hospitalized patients in East azerbaijan province, northwest Iran: a review of 18323 cases. J Tehran Heart Cent. 2013 Apr;8(2):101-5.
Azarfarin R, Sheikhzadeh D, Mirinazhad M, Bilehjani E, Alizadehasl A. Do nondiabetic patients undergoing coronary artery bypass grafting surgery require intraoperative management of hyperglycemia? Acta Anaesthesiol Taiwan. 2011 Jun;49(2):41-5.
Elham Bazmi, Farinaz Mousavi, Leila Giahchin, Tahmineh Mokhtari, and Behnam Behnoush. Cardiovascular Complications of Acute Amphetamine Abuse. Sultan Qaboos Univ Med J. 2017 Feb; 17(1): e31–e37.
Mirinejad M, Azarfarin R, Asl AA. Cisatracurium in cardiac surgerycontinuous infusion vs. bolus administration. Middle East J Anaesthesiol. 2007 Oct;19(3):563-72.
Caccitolo JA, Connolly HM, Rubenson DS, Orszulak TA, Schaff HV. Operation for anorexigen-associated valvular heart disease. J Thorac Cardiovasc Surg. 2001 Oct;122(4):656-64.